199 related articles for article (PubMed ID: 34225603)
21. Hypoxia contributes to development of recurrent endometrial carcinoma.
Pijnenborg JM; Wijnakker M; Hagelstein J; Delvoux B; Groothuis PG
Int J Gynecol Cancer; 2007; 17(4):897-904. PubMed ID: 17359291
[TBL] [Abstract][Full Text] [Related]
22. Synthetically lethal nanoparticles for treatment of endometrial cancer.
Ebeid K; Meng X; Thiel KW; Do AV; Geary SM; Morris AS; Pham EL; Wongrakpanich A; Chhonker YS; Murry DJ; Leslie KK; Salem AK
Nat Nanotechnol; 2018 Jan; 13(1):72-81. PubMed ID: 29203914
[TBL] [Abstract][Full Text] [Related]
23. The Regulatory Role of Lipid Metabolism in Endometrial Cancer.
Zhang S; Han X
J Oncol; 2022; 2022():6458877. PubMed ID: 36072980
[TBL] [Abstract][Full Text] [Related]
24. Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart.
Esteller M; García A; Martínez-Palones JM; Xercavins J; Reventós J
Lab Invest; 1997 Jan; 76(1):109-16. PubMed ID: 9010454
[TBL] [Abstract][Full Text] [Related]
25. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
26. Molecular carcinogenesis of endometrial cancer.
Liu FS
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
[TBL] [Abstract][Full Text] [Related]
27. Clear cell carcinoma of the endometrium.
Bogani G; Ray-Coquard I; Concin N; Ngoi NYL; Morice P; Enomoto T; Takehara K; Denys H; Lorusso D; Coleman R; Vaughan MM; Takano M; Provencher D; Sagae S; Wimberger P; Póka R; Segev Y; Kim SI; Kim JW; Candido Dos Reis FJ; Mariani A; Leitao MM; Makker V; Rustum NA; Vergote I; Zannoni GF; Tan DSP; McCormack M; Bini M; Lopez S; Raspagliesi F; Panici PB; di Donato V; Muzii L; Colombo N; Scambia G; Pignata S; Monk BJ
Gynecol Oncol; 2022 Mar; 164(3):658-666. PubMed ID: 35063279
[TBL] [Abstract][Full Text] [Related]
28. [Molecular based targets and endometrial cancer].
Stoyanov S; Ananiev J; Ivanova K; Velev V; Todorova M; Gulubova M
Akush Ginekol (Sofiia); 2015; 54(2):38-45. PubMed ID: 25909140
[TBL] [Abstract][Full Text] [Related]
29. Induction of human endometrial cancer cell senescence through modulation of HIF-1alpha activity by EGLN1.
Kato H; Inoue T; Asanoma K; Nishimura C; Matsuda T; Wake N
Int J Cancer; 2006 Mar; 118(5):1144-53. PubMed ID: 16161047
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-inducible factor-1α, adrenomedullin and Bcl-2 although expected are not related to increased uptake of fluorine-18-fluorodeoxyglucose in endometrial cancer.
Cerci SS; Yalcin Y; Bozkurt KK; Erdemoglu E; Tatar B; Erdemoglu E
Hell J Nucl Med; 2015; 18(3):228-32. PubMed ID: 26637502
[TBL] [Abstract][Full Text] [Related]
31. LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer.
Kunitomi H; Kobayashi Y; Wu RC; Takeda T; Tominaga E; Banno K; Aoki D
J Gynecol Oncol; 2020 Mar; 31(2):e11. PubMed ID: 31912669
[TBL] [Abstract][Full Text] [Related]
32. [p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumor aggressiveness in humans].
Wild PJ
Pathologe; 2013 Nov; 34 Suppl 2():180-8. PubMed ID: 24196610
[TBL] [Abstract][Full Text] [Related]
33. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
[TBL] [Abstract][Full Text] [Related]
34. Paeonol alleviates migration and invasion of endometrial stromal cells by reducing HIF-1α-regulated autophagy in endometriosis.
Pang C; Wu Z; Xu X; Yang W; Wang X; Qi Y
Front Biosci (Landmark Ed); 2021 Sep; 26(9):485-495. PubMed ID: 34590461
[No Abstract] [Full Text] [Related]
35. Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis.
Reske JJ; Wilson MR; Holladay J; Siwicki RA; Skalski H; Harkins S; Adams M; Risinger JI; Hostetter G; Lin K; Chandler RL
PLoS Genet; 2021 Dec; 17(12):e1009986. PubMed ID: 34941867
[TBL] [Abstract][Full Text] [Related]
36. New concepts in the diagnosis and prognosis of endometrial carcinoma.
Sasano H; Watanabe K; Ito K; Sato S; Yajima A
Pathol Annu; 1994; 29 ( Pt 2)():31-49. PubMed ID: 7936750
[TBL] [Abstract][Full Text] [Related]
37. New candidate therapeutic agents for endometrial cancer: potential for clinical practice (review).
Umene K; Banno K; Kisu I; Yanokura M; Nogami Y; Tsuji K; Masuda K; Ueki A; Kobayashi Y; Yamagami W; Tominaga E; Susumu N; Aoki D
Oncol Rep; 2013 Mar; 29(3):855-60. PubMed ID: 23291663
[TBL] [Abstract][Full Text] [Related]
38. Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors.
Aguilar M; Zhang H; Zhang M; Cantarell B; Sahoo SS; Li HD; Cuevas IC; Lea J; Miller DS; Chen H; Zheng W; Gagan J; Lucas E; Castrillon DH
J Pathol; 2021 May; 254(1):20-30. PubMed ID: 33506979
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia and hypoxia inducible factor-1α are required for normal endometrial repair during menstruation.
Maybin JA; Murray AA; Saunders PTK; Hirani N; Carmeliet P; Critchley HOD
Nat Commun; 2018 Jan; 9(1):295. PubMed ID: 29362355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
